← Evidence map

ReviewThe oncologist2021

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.

Charles L Bennett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions. | OpenQuestion